MarketStreptococcus salivarius
Company Profile

Streptococcus salivarius

Streptococcus salivarius is a species of spherical, gram-positive, facultative anaerobic lactic acid bacteria that is both catalase and oxidase negative. S. salivarius colonizes the oral cavity and upper respiratory tract of humans just a few hours after birth, making further exposure to the bacteria harmless in most circumstances. The bacterium is considered an opportunistic pathogen, rarely finding its way into the bloodstream, where it has been implicated in cases of sepsis in people with neutropenia,.

Role as a probiotic
Some strains of S. salivarius are being trialed for their use as a probiotic in the prevention of oral infections. Some strains of S. salivarius are found to produce BLIS (Bacteriocin-like Inhibitory Substances) which are antimicrobial peptides. These peptides display interspecies inhibition, and inhibit Streptococcus pyogenes (which causes strep throat infections). Lozenges containing S. salivarius are marketed to support immunity against more virulent Streptococcus strains. People with this strain of naturally occurring S. salivarius on their tongue have been shown to have fewer Strep throat infections. This is also being investigated for its potential to prevent rheumatic heart disease which is also caused by S. pyogenes. Agglutination of Streptococcus salivarius is often used in the diagnosis of atypical pneumonia caused by Haemophilus influenzae == Subspecies ==
Subspecies
Streptococcus thermophilus was originally described as a subspecies of this entry, Streptococcus salivarius subsp. thermophilus. It has since been promoted to the species rank. The FastANI metric used by GTDB concurs with this decision. ==References==
tickerdossier.comtickerdossier.substack.com